Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Adagloxad simolenin |
Trade Name | |
Synonyms | OPT-822|OBI 822|OBI822 |
Drug Descriptions |
Adagloxad simolenin (OBI-822) is an immunotherapy comprised of Globo H hexassaccharide 1 and keyhole limpet hemocyanin, which upon treatment, results in a cytotoxic T-cell response against cells expressing Globo H, and thus, may lead to antitumor activity (PMID: 32718986). |
DrugClasses | |
CAS Registry Number | 1458687-85-8 |
NCIT ID | C99766 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Adagloxad simolenin | Adagloxad simolenin | 0 | 0 |
Adagloxad simolenin + Cyclophosphamide + OBI-821 | Adagloxad simolenin Cyclophosphamide OBI-821 | 0 | 0 |
Adagloxad simolenin + OBI-821 | Adagloxad simolenin OBI-821 | 0 | 1 |